Gadolinium-based contrast agents, erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure

Benzer Materyaller

• Association of Gadolinium Based MRI Contrast Agents and Nephrogenic Systemic Fibrosis
  Yazar:: Bhave, Gautam, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Biochemical Safety Profiles of Gadolinium-Based Extracellular Contrast Agents and Nephrogenic Systemic Fibrosis
  Yazar:: Ersoy, Hale, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Gadolinium Contrast Agent-Induced CD163(+) Ferroportin(+) Osteogenic Cells in Nephrogenic Systemic Fibrosis
  Yazar:: Swaminathan, Sundararaman, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis
  Yazar:: Zhang, Bin, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents
  Yazar:: Thomsen, Henrik S., ve diğerleri
  Baskı/Yayın Bilgisi: (2007)